Skip to main content
Erschienen in: Pediatric Nephrology 5/2013

01.05.2013 | Original Article

Low expression of glucocorticoid receptors in children with steroid-resistant nephrotic syndrome

verfasst von: Ayman Hammad, Sohier Yahia, Mona Samy Gouida, Ashraf Bakr, Reham M. El-farahaty

Erschienen in: Pediatric Nephrology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

About 10–20 % of children with idiopathic nephrotic syndrome (NS) are steroid-resistant (SR). Low expression of glucocorticoid receptors (GRs) has been associated with poor response to steroids in a variety of autoimmune diseases. This study was done to assess the expression of cytoplasmic GRs for CD3 and CD14 in children with NS.

Methods

Expression of cytoplasmic GRs in lymphocytes (CD3+/GR) and monocytes (CD14+/GR) in the peripheral blood were assessed in 51 children with NS before the start of therapy by flow cytometry. Patients were divided into two groups: 30 children who were steroid-sensitive (SSNS) and 21 children who had initial steroid resistance (SRNS). Twenty age- and sex-matched healthy children served as controls.

Results

Expression of CD3+/GR was significantly lower in SRNS in comparison to SSNS patients and controls (p < 0.0001). Similarly, expression of CD14+/GR was significantly lower in SRNS in comparison to SSNS patients (p < 0.0001) and controls (p = 0.002). CD3+/GR and CD14+/GR expression were not significantly different in SSNS patients compared with controls (p = 0.06 and 0.07 respectively).

Conclusions

Patients with initial SRNS showed decreased GR expression in peripheral blood mononuclear cells (PBMC) before starting therapy, and this low expression may be one of the pathophysiological mechanisms of steroid resistance in these children.
Literatur
2.
Zurück zum Zitat International Study of Kidney Disease in Children.(1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159–165CrossRef International Study of Kidney Disease in Children.(1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159–165CrossRef
3.
Zurück zum Zitat Bagga A, Mantan M (2005) Nephrotic syndrome in children. Indian J Med Res 122:13–28PubMed Bagga A, Mantan M (2005) Nephrotic syndrome in children. Indian J Med Res 122:13–28PubMed
4.
Zurück zum Zitat Barnes PJ (1998) Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 94:557–572 Barnes PJ (1998) Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 94:557–572
5.
Zurück zum Zitat Barnes PJ, Adcock IM (2009) Glucocorticoid resistance in inflammatory diseases. Lancet 373:1905–1917PubMedCrossRef Barnes PJ, Adcock IM (2009) Glucocorticoid resistance in inflammatory diseases. Lancet 373:1905–1917PubMedCrossRef
6.
Zurück zum Zitat Elie V, Fakhoury M, Deschenes G, Jacqz-Aigrain E (2012) Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives. Pediatr Nephrol 27:1249–1256PubMedCrossRef Elie V, Fakhoury M, Deschenes G, Jacqz-Aigrain E (2012) Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives. Pediatr Nephrol 27:1249–1256PubMedCrossRef
7.
Zurück zum Zitat Grzanka A, Jarzab J, Rogala B (1996) Molecular mechanism of glucocorticoid action. Pol Arch Med Wewn 95:375–382PubMed Grzanka A, Jarzab J, Rogala B (1996) Molecular mechanism of glucocorticoid action. Pol Arch Med Wewn 95:375–382PubMed
8.
Zurück zum Zitat Adcock IM, Lane SJ, Brown CR, Peters MJ, Lee TH, Barnes PJ (1995) Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol 154:3500–3505PubMed Adcock IM, Lane SJ, Brown CR, Peters MJ, Lee TH, Barnes PJ (1995) Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol 154:3500–3505PubMed
9.
Zurück zum Zitat Du J, Li M, Zhang D, Zhu X, Zhang W, Gu W, Feng Y, Zhai X, Ling C (2009) Flow cytometry analysis of glucocorticoid receptor expression and binding in steroid-sensitive and steroid-resistant patients with systemic lupus erythematosus. Arthritis Res Ther 11:R108PubMedCrossRef Du J, Li M, Zhang D, Zhu X, Zhang W, Gu W, Feng Y, Zhai X, Ling C (2009) Flow cytometry analysis of glucocorticoid receptor expression and binding in steroid-sensitive and steroid-resistant patients with systemic lupus erythematosus. Arthritis Res Ther 11:R108PubMedCrossRef
10.
Zurück zum Zitat Schlaghecke R, Kornely E, Wollenhaupt J, Specker C (1992) Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum 35:740–744PubMedCrossRef Schlaghecke R, Kornely E, Wollenhaupt J, Specker C (1992) Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum 35:740–744PubMedCrossRef
11.
Zurück zum Zitat Moalli PA, Rosen ST (1994) Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies. Leuk Lymphoma 15:363–374PubMedCrossRef Moalli PA, Rosen ST (1994) Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies. Leuk Lymphoma 15:363–374PubMedCrossRef
12.
Zurück zum Zitat Bagdasarova IV, Ivanov DD, Afanas’eva VV (1991) The morphofunctional characteristics of the blood lymphocytes in steroid-sensitive and steroid-resistant glomerulonephritis. Arkh Patol 53:28–32PubMed Bagdasarova IV, Ivanov DD, Afanas’eva VV (1991) The morphofunctional characteristics of the blood lymphocytes in steroid-sensitive and steroid-resistant glomerulonephritis. Arkh Patol 53:28–32PubMed
13.
Zurück zum Zitat Shalaby SA, El Idrissy HM, Safar RA, Hussein ST (2012) Glucocorticoid receptors and the pattern of steroid response in idiopathic nephrotic syndrome. Arab J Nephrol Transplant 5:13–17PubMed Shalaby SA, El Idrissy HM, Safar RA, Hussein ST (2012) Glucocorticoid receptors and the pattern of steroid response in idiopathic nephrotic syndrome. Arab J Nephrol Transplant 5:13–17PubMed
14.
Zurück zum Zitat Haack D, Scharer K, Asam-Tauscher A, Vecsei P (1999) Glucocorticoid receptors in idiopathic nephrotic syndrome. Pediatr Nephrol 13:653–656PubMedCrossRef Haack D, Scharer K, Asam-Tauscher A, Vecsei P (1999) Glucocorticoid receptors in idiopathic nephrotic syndrome. Pediatr Nephrol 13:653–656PubMedCrossRef
15.
Zurück zum Zitat Kim EY, Zeng QT, Kuo FC, Rawn J, Mentzer SJ (2003) Visual representation of cell subpopulation from flow cytometry data. AMIA Annu Symp Proc 893 Kim EY, Zeng QT, Kuo FC, Rawn J, Mentzer SJ (2003) Visual representation of cell subpopulation from flow cytometry data. AMIA Annu Symp Proc 893
16.
Zurück zum Zitat Zhang JP, Yan J, Xu J, Pang XH, Chen MS, Li L, Wu C, Li SP, Zheng L (2009) Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol 50:980–989PubMedCrossRef Zhang JP, Yan J, Xu J, Pang XH, Chen MS, Li L, Wu C, Li SP, Zheng L (2009) Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol 50:980–989PubMedCrossRef
17.
Zurück zum Zitat International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98:561–564CrossRef International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98:561–564CrossRef
18.
Zurück zum Zitat Gulati A, Bagga A, Gulati S, Mehta KP, Vijayakumar M (2009) Management of steroid resistant nephrotic syndrome. Indian Pediatr 46:35–47PubMed Gulati A, Bagga A, Gulati S, Mehta KP, Vijayakumar M (2009) Management of steroid resistant nephrotic syndrome. Indian Pediatr 46:35–47PubMed
19.
Zurück zum Zitat Szilagyi K, Podracka L, Franke NE, Mojzis J, Mirossay L (2009) A new link between steroid resistance, glucocorticoid receptor and nuclear factor kappa B p65 in idiopathic nephrotic syndrome. Neuro Endocrinol Lett 30:629–636PubMed Szilagyi K, Podracka L, Franke NE, Mojzis J, Mirossay L (2009) A new link between steroid resistance, glucocorticoid receptor and nuclear factor kappa B p65 in idiopathic nephrotic syndrome. Neuro Endocrinol Lett 30:629–636PubMed
20.
Zurück zum Zitat Aviles DH, Matti Vehaskari V, Manning J, Ochoa AC, Zea AH (2004) Decreased expression of T-cell NF-kappaB p65 subunit in steroid-resistant nephrotic syndrome. Kidney Int 66:60–67PubMedCrossRef Aviles DH, Matti Vehaskari V, Manning J, Ochoa AC, Zea AH (2004) Decreased expression of T-cell NF-kappaB p65 subunit in steroid-resistant nephrotic syndrome. Kidney Int 66:60–67PubMedCrossRef
21.
Zurück zum Zitat Pace TW, Hu F, Miller AH (2007) Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 21:9–19PubMedCrossRef Pace TW, Hu F, Miller AH (2007) Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 21:9–19PubMedCrossRef
22.
Zurück zum Zitat Clement LC, Avila-Casado C, Mace C, Soria E, Bakker WW, Kersten S, Chugh SS (2011) Podocyte secreted Angiopoietin-like 4 mediates proteinuria in glucocorticoid sensitive nephrotic syndrome. Nat Med 17:117–122PubMedCrossRef Clement LC, Avila-Casado C, Mace C, Soria E, Bakker WW, Kersten S, Chugh SS (2011) Podocyte secreted Angiopoietin-like 4 mediates proteinuria in glucocorticoid sensitive nephrotic syndrome. Nat Med 17:117–122PubMedCrossRef
23.
Zurück zum Zitat Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Wiercinski R, Stasiak-Barmuta A (2003) Expression of glucocorticoid receptors in mononuclear cells in nephrotic syndrome. Pediatr Nephrol 18:778–782PubMedCrossRef Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Wiercinski R, Stasiak-Barmuta A (2003) Expression of glucocorticoid receptors in mononuclear cells in nephrotic syndrome. Pediatr Nephrol 18:778–782PubMedCrossRef
24.
Zurück zum Zitat Berki T, Tavakoli A, Nagy KK, Nagy G, Nemeth P (2002) Alterations of glucocorticoid receptor expression during glucocorticoid hormone therapy in renal transplant patients. Transpl Int 15:132–138PubMedCrossRef Berki T, Tavakoli A, Nagy KK, Nagy G, Nemeth P (2002) Alterations of glucocorticoid receptor expression during glucocorticoid hormone therapy in renal transplant patients. Transpl Int 15:132–138PubMedCrossRef
25.
Zurück zum Zitat Munck A, Mendel DB, Smith LI, Orti E (1990) Glucocorticoid receptors and actions. Am Rev Respir Dis 141:S2–S10PubMed Munck A, Mendel DB, Smith LI, Orti E (1990) Glucocorticoid receptors and actions. Am Rev Respir Dis 141:S2–S10PubMed
26.
Zurück zum Zitat Ito K, Chung KF, Adcock IM (2006) Update on glucocorticoid action and resistance. J Allergy Clin Immunol 117:522–543PubMedCrossRef Ito K, Chung KF, Adcock IM (2006) Update on glucocorticoid action and resistance. J Allergy Clin Immunol 117:522–543PubMedCrossRef
27.
Zurück zum Zitat Hurley DM, Accili D, Stratakis CA, Karl M, Vamvakopoulos N, Rorer E, Constantine K, Taylor SI, Chrousos GP (1991) Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 87:680–686PubMedCrossRef Hurley DM, Accili D, Stratakis CA, Karl M, Vamvakopoulos N, Rorer E, Constantine K, Taylor SI, Chrousos GP (1991) Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 87:680–686PubMedCrossRef
Metadaten
Titel
Low expression of glucocorticoid receptors in children with steroid-resistant nephrotic syndrome
verfasst von
Ayman Hammad
Sohier Yahia
Mona Samy Gouida
Ashraf Bakr
Reham M. El-farahaty
Publikationsdatum
01.05.2013
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 5/2013
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-012-2385-4

Weitere Artikel der Ausgabe 5/2013

Pediatric Nephrology 5/2013 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.